The Cyprus Association of Research and Development Pharmaceutical Companies (KEFEA) wishes to inform its members and the companies members of EFPIA active in Cyprus that the Health Ministry has issued a new circular dated 22 June, 2015 amending the procedures...
Pharmaceutical companies say they are trapped because they cannot delete products from the price list There will be problems in the unimpeded distribution of medicines in the Cyprus market, particularly the availability of new, innovative treatments following the...
The Cyprus Association of Research and Development Pharmaceutical Companies (KEFEA) is concerned about the Minister of Health’s decision to proceed with a further 8.5% horizontal price cut on private sector medicines. This latest, one-sided measure may create problems...
Interview with KEFEA President, Kyriakos Mikellis, published in Politis newspaper Read the interview here 20150222KEFEA President interview
Join initiatives by CIPA – KEFEA The potential to attract investments in the pharmaceutical industry and develop joint initiatives to improve the investment climate were discussed during a meeting between the Cyprus Investment Promotion Agency (CIPA) and the Cyprus...
